Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Gianellini
PHA-739358, a Potent Inhibitor of Aurora Kinases With a Selective Target Inhibition Profile Relevant to Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Simultaneous Targeting of Aurora Kinases and BCR-Abl Kinase by the Small Molecule Inhibitor PHA-739358 Is Effective Against Imatinib-Resistant BCR-ABL Mutations Including T315I
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma
Oncotarget
Oncology
SRC Inhibition Is Still a Relevant Target in Pancreatic Cancer
Oncologist
Cancer Research
Medicine
Oncology
Selective Inhibition of IL-Gene Expression by 2Trichostatin A, a Potent Inhibitor of Mammalian Histone Deacetylase.
Journal of Antibiotics
Drug Discovery
Pharmacology
TheIn vitroandIn vivoEffects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases
Cancer Research
Cancer Research
Oncology
Aurora Kinases: Structure, Functions and Their Association With Cancer
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Biochemistry
Medicine
Genetics
Molecular Biology
Dictyostelium Aurora Kinase Has Properties of Both Aurora a and Aurora B Kinases
Eukaryotic Cell
Inhibition of Angiogenesis by Staurosporine, a Potent Protein Kinase Inhibitor.
Journal of Antibiotics
Drug Discovery
Pharmacology
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase With Potent Antimelanoma Activity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
